Subjects | 5 |
Age years | 35.0 (23–65) |
Male | 4 (80) |
Weight kg | 66.8 (55.2–78.5) |
Height m | 1.74 (1.67–1.82) |
Body mass index kg·m−2 | 22.1 (17.1–26.2) |
Ethnicity | |
African | 3 |
Caucasian | 1 |
Asian | 1 |
HIV-positive | 1 |
Isolate resistant to drug based on drug susceptibility testing | |
Ethambutol | 3/5 |
Isoniazid | 5/5 |
Pyrazinamide# | 2/4 |
Rifampicin | 5/5 |
Streptomycin | 4/5 |
Capreomycin | 1/5 |
Amikacin | 0/5 |
Ciprofloxacin | 1/5 |
Clarithromycin# | 2/3 |
Clofazimine# | 0/3 |
Linezolid | 0/5 |
Moxifloxacin | 1/5 |
Protionamide# | 1/4 |
Rifabutin | 4/5 |